Extensive analytical method development services for projects from pre-clinical through to late stage clinical manufacturing.
Upperton offers extensive analytical method and validation services as part of our development services as well as stand-alone analytical testing services for projects throughout each stage of the drug life cycle from pre-clinical through to late phase. Our analytics team specialise in the development of analytical methods to protect quality throughout the programme.
Find out how we supported a dual API degradation project.
Our team have access to a wide range of techniques to support your project.
Successful development programmes begin with a thorough understanding of the physio-chemical characteristics of the API. Additionally, it is important to understand any potential stability or excipient incompatibility challenges.
Using a range of techniques including DSC, TGA, XRPD, Microscopy, FTIR, Particle sizing etc, we gain a fundamental understanding and insight into the behaviours of your API to support the development activities required for first in human studies and product development.
Upperton is home to an extensive number of analytical method development techniques. Please speak to our team directly to find the full list of our techniques.
Once a product enters clinical development, our dedicated analytics team work with you, and with the cross functional teams in our business. We then transfer, develop and create phase appropriate validation of your analytical methods and performance of QC and release testing. This includes:
Our expertise spans:
By combining scientific excellence with practical development expertise, we help overcome the challenges of complex drug products and accelerate their path to clinic and market.
We provide fully integrated services across every stage of drug product development:
How can we help you?